Glutathione Injection

Master Antioxidant

Level C

Editor: Dr. Jobby John, PharmD, FACA

Peptide Ledger review boards: Medical Review Board (Dr. Jobby John, PharmD, FACA; Dr. Richard Harris, MD, PharmD, MBA; Dr. Tracy Neal, MD; Dr. John Thoppil, MD; Dr. Natalie Kash, MD; Dr. Rahil Roopani, MD)Pharmacist Review Committee (Rachel Kuretich, PharmD, PharmD; Daniel Alonso, PharmD, PharmD; Christina Gunter, PharmD, PharmD; Patrick Gurley, PharmD, MS, PharmD, MS; Gyu-Hee Min, PharmD, PharmD)

References are being re-verified against PubMed and will return with review dates.

Emerging Evidence

Preclinical and animal studies with limited human data

Dosing considerations for clinicians

Dosing considerations are available to verified clinicians.

Available through Lake Hills Pharmacy

Available through Lake Hills Pharmacy for verified clinicians. Contact us for more information.

For Healthcare Providers

New to Lake Hills Pharmacy? Join our provider network. Lake Hills Pharmacy is preparing peptide programs as regulatory guidance on compounded peptides develops. Contact us for more information.

For Patients

Interested in Glutathione Injection? Connect with our medical team to discuss if this therapy is right for you.

or call us directly:

Clinical View: Complete drug monograph with evidence-based protocols. Switch to General View for patient-friendly information.

Important Information About Compounded Medications

These peptides are not FDA-approved but are commonly used by providers and patients under medical supervision. These statements have not been evaluated by the FDA. These products are not intended to diagnose, treat, cure, or prevent any disease. We provide evidence-based information from current research to help navigate this evolving field. Our goal is clear, evidence-based information for clinicians, with professional oversight at every step.

Lake Hills Pharmacy | Licensed 503A Compounding Pharmacy | Professional Medical Oversight Required